Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-10-28

FDA Approved: LEUPROLIDE ACETATE — Original Application (Amneal Pharmaceuticals LLC)

View source ↗

Summary

FDA approved Amneal Pharmaceuticals' original ANDA for Leuprolide acetate, a generic version of Lupron.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Leuprolide acetate (Leuprolide acetate)

Snippet

ORIG AP for LEUPROLIDE ACETATE (LEUPROLIDE ACETATE)